Literature DB >> 24596694

Rhabdomyolysis. The role of diagnostic and prognostic factors.

Eran Keltz1, Fahmi Yousef Khan2, Gideon Mann1.   

Abstract

Rhabdomyolysis, literally meaning the breakdown of muscle tissue, is a common syndrome with many causes, acquired ones such as exertion, trauma, infections, temperature extremes, drugs, toxins, electrolyte and endocrine abnormalities, and congenital ones such as myopathies and connective tissue disorders. All results in a common pathophysiologic pathway which ends with the dispersing of muscle tissue content into the circulation. Rhabdomyolysis has characteristic clinical, laboratory and radiologic features, but does require a high index of suspicion so that the diagnosis would not be missed. The sensitivity and specificity of the various characteristics, as well as clinical guidelines, are discussed in this paper. The syndrome may present with several complications, e.g. arrhythmias, electrolyte abnormalities, acute renal injury, acidosis, volume depletion, compartment syndrome and disseminated intravascular coagulation. The prognosis is highly variable and depends on the underlying etiologies and complications, but is in general considered as good. The milestone of treatment is vigorous fluid resuscitation. Treatment options, in practice and in research, are discussed in the following pages.

Entities:  

Keywords:  rhabdomyolysis

Year:  2014        PMID: 24596694      PMCID: PMC3940504     

Source DB:  PubMed          Journal:  Muscles Ligaments Tendons J        ISSN: 2240-4554


  130 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  P Adnet; P Lestavel; R Krivosic-Horber
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 2.  Overview of the muscular dystrophies.

Authors:  Anthony A Amato; Robert C Griggs
Journal:  Handb Clin Neurol       Date:  2011

Review 3.  Rhabdomyolysis: pathogenesis of renal injury and management.

Authors:  Zubaida Al-Ismaili; Melissa Piccioni; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

4.  Salmonella infection-associated acute rhabdomyolysis. Some pathogenic considerations.

Authors:  Nada Brncic; Ivica Viskovic; Antun Sasso; Ivan Kraus; Gordana Zamolo
Journal:  Arch Med Res       Date:  2002 May-Jun       Impact factor: 2.235

5.  Natural history of exertional rhabdomyolysis: a population-based analysis.

Authors:  Joshua P Alpers; Lyell K Jones
Journal:  Muscle Nerve       Date:  2010-10       Impact factor: 3.217

6.  Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis.

Authors:  Kimbra Kenney; Mark E Landau; Rodney S Gonzalez; Julie Hundertmark; Karen O'Brien; William W Campbell
Journal:  Muscle Nerve       Date:  2012-03       Impact factor: 3.217

7.  Hyperosmolar hyperglycemic syndrome with rhabdomyolysis.

Authors:  Mary E Stunkard; Valerie T Pikul; Kevin Foley
Journal:  Clin Lab Sci       Date:  2011

8.  Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.

Authors:  M Tahmaz; B Kumbasar; K Ergen; U Ure; G Karatemiz; R Kazancioglu
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

9.  Retrospective review of the frequency of ECG changes in hyperkalemia.

Authors:  Brian T Montague; Jason R Ouellette; Gregory K Buller
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 10.  Relative safety profiles of high dose statin regimens.

Authors:  Carlos Escobar; Rocio Echarri; Vivencio Barrios
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  35 in total

1.  Surgical treatment for muscle injuries.

Authors:  Leonardo Addêo Ramos; Rogério Teixeira de Carvalho; Rene Jorge Abdalla; Sheila Jean McNeill Ingham
Journal:  Curr Rev Musculoskelet Med       Date:  2015-06

2.  Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Authors:  Dominic Mitchell; Jason R Guertin; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

3.  A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Authors:  Dominic Mitchell; Jason R Guertin; Anick Dubois; Marie-Pierre Dubé; Jean-Claude Tardif; Ange Christelle Iliza; Fiorella Fanton-Aita; Alexis Matteau; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  Is dilution important: Factitious Total Creatine Kinase in case of Rhabdomyolysis?

Authors:  Sunil Kumar Nanda; Asha Dinakaran; Lopamudra Ray
Journal:  J Clin Diagn Res       Date:  2016-10-01

5.  Rhabdomyolysis observed at forensic autopsy: a series of 52 cases.

Authors:  Hsuan-Yun Hu; Shyh-Yuh Wei; Chih-Hsin Pan
Journal:  Forensic Sci Med Pathol       Date:  2018-07-28       Impact factor: 2.007

Review 6.  A "crush" course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician.

Authors:  Devan R Cote; Eva Fuentes; Ali H Elsayes; Jonathan J Ross; Sadeq A Quraishi
Journal:  J Anesth       Date:  2020-05-18       Impact factor: 2.078

7.  Severe localized scapular pain after a strenuous weight-lifting session.

Authors:  Rosamond E Lougheed Simpson; Steven R Joseph; Lisa Fischer
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

Review 8.  Volume Resuscitation in Patients With High-Voltage Electrical Injuries.

Authors:  Derek M Culnan; Kelley Farner; Genevieve H Bitz; Karel D Capek; Yiji Tu; Carlos Jimenez; William C Lineaweaver
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

9.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 10.  Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.

Authors:  Zhining Wen; Yu Liang; Yingyi Hao; Brian Delavan; Ruili Huang; Mike Mikailov; Weida Tong; Menglong Li; Zhichao Liu
Journal:  Drug Discov Today       Date:  2018-06-11       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.